Kaizen Advisory’s Hologic HOLX Stock Holding History

Kaizen Advisory’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$29K	Buy	712 +7	+1%	+$287	0.02%	444
2018 Q3	$29K	Hold	705	–	–	0.02%	455
2018 Q2	$28K	Buy	705 +441	+167%	+$17K	0.01%	467
2018 Q1	$10K	Hold	264	–	–	0.01%	482
2017 Q4	$11K	Buy	+264	New	+$10.5K	0.01%	458

Other funds holding HOLX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Kaizen Advisory's HOLX Position: Q4 2018 in Review

Kaizen Advisory increased its Hologic (HOLX) stake by 0.99% in Q4 2018, buying an estimated $287 and bringing the position to 712 shares worth $29K. The position accounts for 0.02% of the portfolio, ranked #444.

Kaizen Advisory first reported a position in HOLX in Q4 2017 and has held it in 5 quarters since. 468 funds tracked by Wall St. Rank hold HOLX as of Q4 2018.

Kaizen Advisory held 712 shares of Hologic worth $29K as of Q4 2018.
Kaizen Advisory bought 7 Hologic shares in Q4 2018, an estimated $287.
Hologic made up 0.02% of Kaizen Advisory's portfolio in Q4 2018, its #444 holding.
Kaizen Advisory first reported a position in Hologic in Q4 2017 and has held it in 5 quarters since.
468 funds tracked by Wall St. Rank held Hologic as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.